Literature DB >> 23127958

Characterization of the mutant β-subunit of β-hexosaminidase for dimer formation responsible for the adult form of Sandhoff disease with the motor neuron disease phenotype.

Kenichiro Yamada1, Yuhei Takado, Yusuke S Kato, Yasukazu Yamada, Hideaki Ishiguro, Nobuaki Wakamatsu.   

Abstract

The adult form of Sandhoff disease with the motor neuron disease phenotype is a rare neurodegenerative disorder caused by mutations in HEXB encoding the β-subunit of β-hexosaminidase, yet the properties of mutant β-subunits of the disease have not been fully determined. We identified a novel mutation (H235Y) in the β-sheet of the (β/α)₈-barrel domain, in addition to the previously reported P417L mutation that causes aberrant splicing, in a Japanese patient with the motor neuron disease phenotype. Enzyme assays, gel filtration studies and immunoprecipitation studies with HEK293 cells transiently expressing mutant β-subunits demonstrated that the H235Y mutation abolished both α-β and β-β dimer formation without increasing β-hexosaminidase activity, whereas other reported mutant β-subunits (Y456S, P504S or R533H) associated with the motor neuron disease phenotype formed dimers. Structural analysis suggested that the H235Y mutation in the β-sheet of the (β/α)₈-barrel domain changed the conformation of the β-subunit by causing a clash with the E288 side chain. In summary, H235Y is the first mutation in the β-sheet of the (β/α)₈-barrel domain of the β-subunit that abolishes α-β and β-β dimer formation; the presented patient is the second patient to exhibit the motor neuron disease phenotype with P417L and a non-functional allele of HEXB.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23127958      PMCID: PMC3528005          DOI: 10.1093/jb/mvs131

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  26 in total

Review 1.  Stability, catalytic versatility and evolution of the (beta alpha)(8)-barrel fold.

Authors:  B Höcker; C Jürgens; M Wilmanns; R Sterner
Journal:  Curr Opin Biotechnol       Date:  2001-08       Impact factor: 9.740

2.  UCSF Chimera--a visualization system for exploratory research and analysis.

Authors:  Eric F Pettersen; Thomas D Goddard; Conrad C Huang; Gregory S Couch; Daniel M Greenblatt; Elaine C Meng; Thomas E Ferrin
Journal:  J Comput Chem       Date:  2004-10       Impact factor: 3.376

3.  Molecular basis of an adult form of beta-hexosaminidase B deficiency with motor neuron disease.

Authors:  P Banerjee; L Siciliano; D Oliveri; N R McCabe; M J Boyers; A L Horwitz; S C Li; G Dawson
Journal:  Biochem Biophys Res Commun       Date:  1991-11-27       Impact factor: 3.575

Review 4.  The TIM-barrel fold: a versatile framework for efficient enzymes.

Authors:  R K Wierenga
Journal:  FEBS Lett       Date:  2001-03-16       Impact factor: 4.124

5.  The X-ray crystal structure of human beta-hexosaminidase B provides new insights into Sandhoff disease.

Authors:  Timm Maier; Norbert Strater; Christina G Schuette; Ralf Klingenstein; Konrad Sandhoff; Wolfram Saenger
Journal:  J Mol Biol       Date:  2003-05-02       Impact factor: 5.469

6.  Crystal structure of human beta-hexosaminidase B: understanding the molecular basis of Sandhoff and Tay-Sachs disease.

Authors:  Brian L Mark; Don J Mahuran; Maia M Cherney; Dalian Zhao; Spencer Knapp; Michael N G James
Journal:  J Mol Biol       Date:  2003-04-11       Impact factor: 5.469

7.  Association of alpha- and beta-subunits during the biosynthesis of beta-hexosaminidase in cultured human fibroblasts.

Authors:  R L Proia; A d'Azzo; E F Neufeld
Journal:  J Biol Chem       Date:  1984-03-10       Impact factor: 5.157

8.  A novel exon mutation in the human beta-hexosaminidase beta subunit gene affects 3' splice site selection.

Authors:  N Wakamatsu; H Kobayashi; T Miyatake; S Tsuji
Journal:  J Biol Chem       Date:  1992-02-05       Impact factor: 5.157

9.  Adult onset motor neuronopathy in the juvenile type of hexosaminidase A and B deficiency.

Authors:  M Rubin; G Karpati; L S Wolfe; S Carpenter; M H Klavins; D J Mahuran
Journal:  J Neurol Sci       Date:  1988-10       Impact factor: 3.181

10.  Ganglioside storage, hexosaminidase lability, and urinary oligosaccharides in adult Sandhoff's disease.

Authors:  P A Bolhuis; J G Oonk; P E Kamp; A J Ris; J C Michalski; B Overdijk; A J Reuser
Journal:  Neurology       Date:  1987-01       Impact factor: 9.910

View more
  5 in total

1.  P. Ala278Val mutation might cause a pathogenic defect in HEXB folding leading to the Sandhoff disease.

Authors:  Zahra Rahmani; Arsham Banisadr; Vadieh Ghodsinezhad; Mohsen Dibaj; Omid Aryani
Journal:  Metab Brain Dis       Date:  2022-10-03       Impact factor: 3.655

2.  Clinical and biochemical characterization of 3-hydroxyisobutyryl-CoA hydrolase (HIBCH) deficiency that causes Leigh-like disease and ketoacidosis.

Authors:  Kenichiro Yamada; Misako Naiki; Shin Hoshino; Yasuyuki Kitaura; Yusuke Kondo; Noriko Nomura; Reiko Kimura; Daisuke Fukushi; Yasukazu Yamada; Nobuyuki Shimozawa; Seiji Yamaguchi; Yoshiharu Shimomura; Kiyokuni Miura; Nobuaki Wakamatsu
Journal:  Mol Genet Metab Rep       Date:  2014-10-16

3.  Natural history of motor neuron disease in adult onset GM2-gangliosidosis: A case report with 25 years of follow-up.

Authors:  Mauro Scarpelli; Giuliano Tomelleri; Laura Bertolasi; Alessandro Salviati
Journal:  Mol Genet Metab Rep       Date:  2014-07-02

4.  Genotype-phenotype correlation of gangliosidosis mutations using in silico tools and homology modeling.

Authors:  Li Ou; Sarah Kim; Chester B Whitley; Jeanine R Jarnes-Utz
Journal:  Mol Genet Metab Rep       Date:  2019-07-17

5.  Tay-Sachs disease mutations in HEXA target the α chain of hexosaminidase A to endoplasmic reticulum-associated degradation.

Authors:  Devin Dersh; Yuichiro Iwamoto; Yair Argon
Journal:  Mol Biol Cell       Date:  2016-09-28       Impact factor: 4.138

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.